GoodRx Introduces New E-commerce Experience for Retail Pharmacies GoodRx, a recognized leader in medication savings platforms across the United States, has announced the introduction of a transformative e-commerce experience designed…
The HRT Club and MyMenopauseRX Team Up to Expand Menopausal Care Access Across 21 States In a major step toward improving access to affordable and patient-centered menopause healthcare, The HRT…
eClinical Solutions Highlights 2025 Shift to Risk-Based Strategies and AI in Clinical Trials eClinical Solutions LLC, a global leader in digital clinical software and services, has released the findings of…
Tecan Enhances Specialty Diagnostics Portfolio With ELISA Kit Asset Acquisition Tecan Group (SIX Swiss Exchange: TECN) has announced a strategic agreement to acquire key ELISA immunoassay assets from Cisbio Bioassays…
Sangamo Licenses Capsid Tech to Lilly for CNS Genomic Medicines Sangamo Therapeutics, Inc., a leader in genomic medicine, has entered into a new licensing agreement with Eli Lilly and Company…
Perth Biosciences Collaborates with Japan’s Scrum Corporation for Distribution Perth Biosciences, a pioneering leader in the accessibility and scalability of single-cell sequencing, has officially announced a strategic agreement with Tokyo-based…
Revvity, Inc. (NYSE: RVTY) has announced that the U.S. Food and Drug Administration (FDA) has granted approval for the Auto-Pure 2400 liquid handling platform in combination with the T-SPOT.TB test.…
Endeavor BioMedicines Welcomes ILD Expert Dr. Lisa Lancaster as Chief Medical Officer Endeavor BioMedicines, a clinical-stage biotechnology company dedicated to developing groundbreaking treatments for life-threatening diseases, has announced the appointment…
Thermo Fisher Unveils Krios 5 Cryo-TEM for Enhanced Automation & Performance Thermo Fisher Scientific, a global leader in scientific innovation, has introduced the Thermo Scientific™ Krios™ 5 Cryo-TEM, a cutting-edge,…
J&J Finalizes Intra-Cellular Therapies Acquisition, Strengthens Neuroscience Leadership Johnson & Johnson (NYSE: JNJ) has officially completed its acquisition of Intra-Cellular Therapies, Inc., marking a significant expansion of its neuroscience portfolio.…
Columbus Unites to Support Life-Saving Research and Patient Care at the 2025 Susan G. Komen Race for the Cure Susan G. Komen®, the world’s leading breast cancer organization, has announced…
Personalized Cancer Vaccine Market & Clinical Trials Outlook 2025 – 18+ Vaccines in Development The “Personalized Cancer Vaccine Market Opportunity & Clinical Trials Outlook 2025″ report, now available from ResearchAndMarkets.com,…